6alpha,7alpha-Dihydroxy-3-oxo-5beta-cholan-24-oic Acid

Metabolite details

Identifier

RTDKESWUGVPWNC-NWZYANAMSA-N

InChI Key

RTDKESWUGVPWNC-NWZYANAMSA-N

IUPAC name

(4R)-4-[(5R,6R,7S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid

Preferred name

6alpha,7alpha-Dihydroxy-3-oxo-5beta-cholan-24-oic Acid

INN name

—

Synonym

—

ChEBI

CHEBI:184206

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Observed in differential profiles

• Control_16.6_months_vs_Treatment_16.6_months
• Control_vs_Exercise
• Control_vs_ZYP_High_Dose